Diabetic ketoacidosis risk in patients taking SGLT2 inhibitors goes beyond the perioperative period and is more often associated with acute illness and infection, according to case reports presented at the Australasian Diabetes Congress in Sydney. A review of 21 cases of SGLT2 inhibitor-associated DKA at Blacktown Hospital, NSW, found that most cases were precipitated by ...
ADC 2019: Australian reports shed light on SGLT2-related DKA
By Michael Woodhead
22 Aug 2019